This Abbot poster caught my eye http://www1.easl.eu/easl2011/program/Posters/Abstract1097.htm specifically the drop outs in the Placebo arm. I take it that presuming VRTX and MRK get their compounds approved future trials will have to compare to one of the PI's+PEG/Riba? If not and I were a patient I would ask to see viral load numbers with each blood draw and make my own conclusions. Wonder if there will be a mad rush of companies trying to enroll their trials before hand.